AMZN
Amazon.com, Inc.
AMZN has the edge over MCD overall, supported by stronger modeled upside and stronger valuation.
MCD
McDonald's Corporation
MCD's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MCD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
MCD's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
MCD PE Valuation
MCD has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over MCD on the outlook, with more favorable revenue expectations.
MCD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect MCD's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the stronger earnings trend. Trailing diluted EPS is up 75% for AMZN versus MCD up 0.4%.
MCD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.34 | +17% |
| Q3 2024 | $11.38 | +0.4% |
| Q2 2024 | $11.42 | +5.3% |
| Q1 2024 | $11.77 | +27% |
| Q4 2023 | $11.56 | +39% |
| Q3 2023 | $11.34 | +43% |
| Q2 2023 | $10.85 | +34% |
| Q1 2023 | $9.30 | -1.8% |
| Q4 2022 | $8.33 | -17% |
MCD earned $11.38 per share over the past year, about the same as the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MCD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
MCD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2B | +1.1% |
| Q2 2026 | $7.1B | +3.7% |
| Q1 2026 | $6.5B | +9.4% |
| Q4 2025 | $7B | +9.7% |
| Q3 2025 | $7.1B | +3% |
| Q2 2025 | $6.8B | +5.4% |
| Q1 2025 | $6B | -3.5% |
| Q4 2024 | $6.4B | -0.3% |
MCD's revenue has grown year over year for six quarters in a row: $7.2B last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +2.8 points |
| Q2 2026 | 47% | -0.2 points |
| Q1 2026 | 45% | +0.9 points |
| Q4 2025 | 45% | +0.1 points |
| Q3 2025 | 47% | +1 points |
| Q2 2025 | 47% | +2.2 points |
| Q1 2025 | 44% | +0.1 points |
| Q4 2024 | 45% | +1.2 points |
MCD has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MCD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.1B | -11% |
| Q2 2026 | $2B | +58% |
| Q1 2026 | $1.7B | -7.8% |
| Q4 2025 | $1.6B | -10% |
| Q3 2025 | $2.4B | +24% |
| Q2 2025 | $1.3B | +18% |
| Q1 2025 | $1.9B | +1.8% |
| Q4 2024 | $1.8B | +5.3% |
MCD has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MCD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -2.7M shares |
| 1 year | -1.1% | -7.9M shares |
| 3 years | -2.5% | -18.4M shares |
MCD has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $519M |
| Q2 2026 | $856M |
| Q1 2026 | $396M |
| Q4 2025 | $573M |
| Q3 2025 | $501M |
| Q2 2025 | $505M |
| Q1 2025 | $477M |
| Q4 2024 | $503M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over MCD on leverage, with a lower net debt burden relative to earnings.
MCD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.1x | Elevated |
MCD's net debt is about 2.9 years of its operating earnings (EBITDA), down from 3.1 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MCD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 76.5 | Neutral |
MCD's weekly RSI is 54 (neutral) and its Stochastic is 77 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MCD PE vs Consumer Cyclical Sector
| Metric | MCD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MCD has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MCD on trend strength, trading above more of its moving averages.
MCD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $250.4 | 9.3% above |
| 20 week MA | $260.1 | 5.2% above |
| 50 week MA | $286.6 | 4.5% below |
| 100 week MA | $295.0 | 7.2% below |
| 200 week MA | $287.9 | 5% below |
MCD has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 5% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MCD on returns for 2026, with the stronger performance.
MCD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $198.2 | $211.4 | +6.7% |
| 2021 | $211.4 | $266.0 | +26% |
| 2022 | $266.0 | $267.6 | +0.6% |
| 2023 | $267.6 | $296.5 | +11% |
| 2024 | $296.5 | $293.6 | -1% |
| 2025 | $293.6 | $310.7 | +5.8% |
| 2026 YTD | $310.7 | $273.6 | -12% |
MCD has finished higher in five of the last six years. It's down 12% so far in 2026.